LifeMD: A Derivative Beneficiary Of The Demand For Anti-Obesity PharmaceuticalsSeeking Alpha • 08/16/23
LifeMD Reports Second Quarter 2023 Results; Achieves Positive Free Cash Flow and Raises 2023 Revenue GuidanceGlobeNewsWire • 08/09/23
LifeMD Elevates Successful GLP-1 Weight Management Program with Proprietary Platform EnhancementsGlobeNewsWire • 06/27/23
LifeMD, Inc. Reports First Quarter 2023 Results; Record Revenues and Adjusted EBITDAGlobeNewsWire • 05/12/23
LifeMD, Inc. to Announce First Quarter 2023 Financial Results on May 12, 2023GlobeNewsWire • 05/03/23
LifeMD Launches New Features and Membership Plans to Improve Patient Experience and Broaden Access to HealthcareGlobeNewsWire • 04/24/23
LifeMD, Inc. Reports Fourth Quarter/ Full Year 2022 Results; Achieves Consolidated Adjusted EBITDA ProfitabilityGlobeNewsWire • 03/22/23
LifeMD, Inc. to Announce Fourth Quarter, Full Year 2022 Financial Results on March 22, 2023GlobeNewsWire • 03/07/23
LifeMD Appoints Jessica Friedeman as Chief Marketing Officer to Support the Company's Rapid Expansion into Virtual Primary CareGlobeNewsWire • 01/04/23